Seconda Universita Di Napoli

At Seconda Universita Di Napoli, clinical research in Hemic and Lymphatic Diseases focuses mainly on acute lymphoblastic leukemia and Langerhans Cell Histiocytosis. The trials are designed to improve survival, reduce relapse, and refine treatment strategies for children and adolescents.

• Testing new treatment approaches for Philadelphia chromosome-positive acute lymphoblastic leukemia
• Evaluating therapy options for pediatric B-ALL and T-ALL based on disease risk and response
• Studying ways to lower reactivation and late effects in Langerhans Cell Histiocytosis

These studies aim to make care more effective and better tailored to young patients with blood-related cancers and immune system disorders.

Research in Neoplasms at this site includes colon cancer and metastatic gastric adenocarcinoma, with a strong interest in improving cancer control and treatment response. The work includes testing new combinations and comparing treatment effectiveness in gastrointestinal cancers.

• Assessing new approaches for colorectal cancer to strengthen immune-based treatment
• Comparing therapies for HER2-positive gastric cancer and gastro-esophageal junction disease
• Exploring options to improve outcomes in advanced pMMR/MSS tumors

The research reflects a broader effort to improve outcomes for patients with hard-to-treat solid tumors through more targeted and innovative therapies.

Clinical trials in Hormonal diseases are centered on growth disorders in children, including those born small for gestational age and children with Turner syndrome, Noonan syndrome, or idiopathic short stature. The goal is to evaluate treatments that may support healthier growth over time.

• Comparing growth treatment options for children with short stature
• Studying treatment effectiveness across SGA, Turner syndrome, Noonan syndrome, and idiopathic short stature
• Focusing on improved growth outcomes and practical long-term care

This area highlights pediatric endocrinology research aimed at helping children reach better growth potential through more convenient and effective therapies.